Chemicals - Specialty
Compare Stocks
4 / 10Stock Comparison
IOSP vs BCPC vs HWKN vs IFF
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals - Specialty
Chemicals - Specialty
IOSP vs BCPC vs HWKN vs IFF — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $1.91B | $5.11B | $3.46B | $19.99B |
| Revenue (TTM) | $1.78B | $1.06B | $1.06B | $10.79B |
| Net Income (TTM) | $117M | $158M | $82M | $839M |
| Gross Margin | 27.7% | 36.3% | 22.9% | 35.1% |
| Operating Margin | 8.7% | 21.0% | 11.5% | 8.0% |
| Forward P/E | 15.5x | 30.9x | 42.3x | 17.8x |
| Total Debt | $90M | $192M | $160M | $6.65B |
| Cash & Equiv. | $293M | $75M | $5M | $590M |
IOSP vs BCPC vs HWKN vs IFF — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Innospec Inc. (IOSP) | 100 | 99.4 | -0.6% |
| Balchem Corporation (BCPC) | 100 | 158.5 | +58.5% |
| Hawkins, Inc. (HWKN) | 100 | 778.6 | +678.6% |
| International Flavo… (IFF) | 100 | 58.8 | -41.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IOSP vs BCPC vs HWKN vs IFF
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IOSP is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.
- Dividend streak 12 yrs, beta 0.70, yield 2.2%
- PEG 0.48 vs BCPC's 2.41
- Beta 0.70, yield 2.2%, current ratio 2.79x
- Lower P/E (15.5x vs 17.8x)
BCPC carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 8.8%, EPS growth 20.9%, 3Y rev CAGR 3.2%
- Lower volatility, beta 0.33, Low D/E 15.3%, current ratio 2.07x
- 8.8% revenue growth vs IFF's -5.2%
- 15.0% margin vs IOSP's 6.6%
HWKN is the clearest fit if your priority is long-term compounding.
- 7.7% 10Y total return vs BCPC's 160.5%
- +40.6% vs IOSP's -14.9%
IFF lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.8% revenue growth vs IFF's -5.2% | |
| Value | Lower P/E (15.5x vs 17.8x) | |
| Quality / Margins | 15.0% margin vs IOSP's 6.6% | |
| Stability / Safety | Beta 0.33 vs HWKN's 0.98, lower leverage | |
| Dividends | 2.2% yield, 12-year raise streak, vs BCPC's 0.5% | |
| Momentum (1Y) | +40.6% vs IOSP's -14.9% | |
| Efficiency (ROA) | 9.4% ROA vs IFF's 3.3%, ROIC 12.2% vs 3.5% |
IOSP vs BCPC vs HWKN vs IFF — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
IOSP vs BCPC vs HWKN vs IFF — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
IOSP leads in 2 of 6 categories
BCPC leads 1 • HWKN leads 1 • IFF leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BCPC leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
IFF is the larger business by revenue, generating $10.8B annually — 10.2x BCPC's $1.1B. BCPC is the more profitable business, keeping 15.0% of every revenue dollar as net income compared to IOSP's 6.6%. On growth, BCPC holds the edge at +8.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1.8B | $1.1B | $1.1B | $10.8B |
| EBITDAEarnings before interest/tax | $198M | $267M | $172M | $1.7B |
| Net IncomeAfter-tax profit | $117M | $158M | $82M | $839M |
| Free Cash FlowCash after capex | $88M | $182M | $88M | $400M |
| Gross MarginGross profit ÷ Revenue | +27.7% | +36.3% | +22.9% | +35.1% |
| Operating MarginEBIT ÷ Revenue | +8.7% | +21.0% | +11.5% | +8.0% |
| Net MarginNet income ÷ Revenue | +6.6% | +15.0% | +7.8% | +7.8% |
| FCF MarginFCF ÷ Revenue | +4.9% | +17.2% | +8.2% | +3.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.4% | +8.1% | +7.9% | -3.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +167.7% | +10.6% | -4.2% | +116.6% |
Valuation Metrics
IOSP leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 16.4x trailing earnings, IOSP trades at a 60% valuation discount to HWKN's 41.4x P/E. Adjusting for growth (PEG ratio), IOSP offers better value at 0.51x vs BCPC's 2.62x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.9B | $5.1B | $3.5B | $20.0B |
| Enterprise ValueMkt cap + debt − cash | $1.7B | $5.2B | $3.6B | $26.1B |
| Trailing P/EPrice ÷ TTM EPS | 16.41x | 33.58x | 41.44x | -53.60x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.45x | 30.87x | 42.31x | 17.84x |
| PEG RatioP/E ÷ EPS growth rate | 0.51x | 2.62x | 1.67x | — |
| EV / EBITDAEnterprise value multiple | 8.29x | 19.83x | 22.74x | 13.28x |
| Price / SalesMarket cap ÷ Revenue | 1.07x | 4.92x | 3.55x | 1.84x |
| Price / BookPrice ÷ Book value/share | 1.44x | 4.14x | 7.60x | 1.41x |
| Price / FCFMarket cap ÷ FCF | 21.68x | 29.51x | 49.48x | 78.09x |
Profitability & Efficiency
Evenly matched — IOSP and BCPC and HWKN each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
HWKN delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $6 for IFF. IOSP carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to IFF's 0.47x. On the Piotroski fundamental quality scale (0–9), BCPC scores 9/9 vs IFF's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.0% | +12.4% | +15.9% | +5.9% |
| ROA (TTM)Return on assets | +6.5% | +9.4% | +8.4% | +3.3% |
| ROICReturn on invested capital | +11.2% | +12.2% | +15.9% | +3.5% |
| ROCEReturn on capital employed | +11.0% | +14.8% | +19.3% | +4.4% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 9 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.07x | 0.15x | 0.35x | 0.47x |
| Net DebtTotal debt minus cash | -$203M | $117M | $155M | $6.1B |
| Cash & Equiv.Liquid assets | $293M | $75M | $5M | $590M |
| Total DebtShort + long-term debt | $90M | $192M | $160M | $6.7B |
| Interest CoverageEBIT ÷ Interest expense | — | 15.23x | 10.27x | 5.26x |
Total Returns (Dividends Reinvested)
HWKN leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HWKN five years ago would be worth $49,115 today (with dividends reinvested), compared to $6,190 for IFF. Over the past 12 months, HWKN leads with a +40.6% total return vs IOSP's -14.9%. The 3-year compound annual growth rate (CAGR) favors HWKN at 61.2% vs IOSP's -6.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +0.5% | +3.6% | +15.1% | +15.6% |
| 1-Year ReturnPast 12 months | -14.9% | -2.2% | +40.6% | +8.5% |
| 3-Year ReturnCumulative with dividends | -17.3% | +26.6% | +318.9% | -13.2% |
| 5-Year ReturnCumulative with dividends | -18.3% | +24.2% | +391.1% | -38.1% |
| 10-Year ReturnCumulative with dividends | +84.4% | +160.5% | +765.9% | -12.6% |
| CAGR (3Y)Annualised 3-year return | -6.1% | +8.2% | +61.2% | -4.6% |
Risk & Volatility
Evenly matched — BCPC and IFF each lead in 1 of 2 comparable metrics.
Risk & Volatility
BCPC is the less volatile stock with a 0.33 beta — it tends to amplify market swings less than HWKN's 0.98 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IFF currently trades 93.0% from its 52-week high vs IOSP's 80.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.70x | 0.33x | 0.98x | 0.68x |
| 52-Week HighHighest price in past year | $95.55 | $183.90 | $186.15 | $84.19 |
| 52-Week LowLowest price in past year | $65.58 | $139.17 | $115.35 | $59.14 |
| % of 52W HighCurrent price vs 52-week peak | +80.2% | +86.7% | +89.7% | +93.0% |
| RSI (14)Momentum oscillator 0–100 | 59.1 | 32.9 | 62.9 | 72.5 |
| Avg Volume (50D)Average daily shares traded | 221K | 190K | 169K | 1.6M |
Analyst Outlook
IOSP leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: IOSP as "Hold", BCPC as "Buy", HWKN as "Buy", IFF as "Buy". Consensus price targets imply 50.1% upside for IOSP (target: $115) vs 1.6% for BCPC (target: $162). For income investors, IOSP offers the higher dividend yield at 2.21% vs HWKN's 0.42%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $115.00 | $162.00 | — | $87.75 |
| # AnalystsCovering analysts | 9 | 10 | 1 | 33 |
| Dividend YieldAnnual dividend ÷ price | +2.2% | +0.5% | +0.4% | +2.0% |
| Dividend StreakConsecutive years of raises | 12 | 11 | 5 | 0 |
| Dividend / ShareAnnual DPS | $1.70 | $0.87 | $0.70 | $1.60 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.1% | +0.7% | +0.2% |
IOSP leads in 2 of 6 categories (Valuation Metrics, Analyst Outlook). BCPC leads in 1 (Income & Cash Flow). 2 tied.
IOSP vs BCPC vs HWKN vs IFF: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IOSP or BCPC or HWKN or IFF a better buy right now?
For growth investors, Balchem Corporation (BCPC) is the stronger pick with 8.
8% revenue growth year-over-year, versus -5. 2% for International Flavors & Fragrances Inc. (IFF). Innospec Inc. (IOSP) offers the better valuation at 16. 4x trailing P/E (15. 5x forward), making it the more compelling value choice. Analysts rate Balchem Corporation (BCPC) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IOSP or BCPC or HWKN or IFF?
On trailing P/E, Innospec Inc.
(IOSP) is the cheapest at 16. 4x versus Hawkins, Inc. at 41. 4x. On forward P/E, Innospec Inc. is actually cheaper at 15. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Innospec Inc. wins at 0. 48x versus Balchem Corporation's 2. 41x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — IOSP or BCPC or HWKN or IFF?
Over the past 5 years, Hawkins, Inc.
(HWKN) delivered a total return of +391. 1%, compared to -38. 1% for International Flavors & Fragrances Inc. (IFF). Over 10 years, the gap is even starker: HWKN returned +765. 9% versus IFF's -12. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IOSP or BCPC or HWKN or IFF?
By beta (market sensitivity over 5 years), Balchem Corporation (BCPC) is the lower-risk stock at 0.
33β versus Hawkins, Inc. 's 0. 98β — meaning HWKN is approximately 198% more volatile than BCPC relative to the S&P 500. On balance sheet safety, Innospec Inc. (IOSP) carries a lower debt/equity ratio of 7% versus 47% for International Flavors & Fragrances Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — IOSP or BCPC or HWKN or IFF?
By revenue growth (latest reported year), Balchem Corporation (BCPC) is pulling ahead at 8.
8% versus -5. 2% for International Flavors & Fragrances Inc. (IFF). On earnings-per-share growth, the picture is similar: Innospec Inc. grew EPS 228. 9% year-over-year, compared to -253. 7% for International Flavors & Fragrances Inc.. Over a 3-year CAGR, HWKN leads at 8. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IOSP or BCPC or HWKN or IFF?
Balchem Corporation (BCPC) is the more profitable company, earning 14.
9% net margin versus -3. 4% for International Flavors & Fragrances Inc. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BCPC leads at 21. 1% versus 8. 8% for IOSP. At the gross margin level — before operating expenses — BCPC leads at 35. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IOSP or BCPC or HWKN or IFF more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Innospec Inc. (IOSP) is the more undervalued stock at a PEG of 0. 48x versus Balchem Corporation's 2. 41x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Innospec Inc. (IOSP) trades at 15. 5x forward P/E versus 42. 3x for Hawkins, Inc. — 26. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IOSP: 50. 1% to $115. 00.
08Which pays a better dividend — IOSP or BCPC or HWKN or IFF?
All stocks in this comparison pay dividends.
Innospec Inc. (IOSP) offers the highest yield at 2. 2%, versus 0. 4% for Hawkins, Inc. (HWKN).
09Is IOSP or BCPC or HWKN or IFF better for a retirement portfolio?
For long-horizon retirement investors, Balchem Corporation (BCPC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
33), 0. 5% yield, +160. 5% 10Y return). Both have compounded well over 10 years (BCPC: +160. 5%, HWKN: +765. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IOSP and BCPC and HWKN and IFF?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: IOSP is a small-cap deep-value stock; BCPC is a small-cap quality compounder stock; HWKN is a small-cap quality compounder stock; IFF is a mid-cap quality compounder stock. IOSP, BCPC, IFF pay a dividend while HWKN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.